News summary

[Kanglon Chemical Corporation and AstraZeneca China reach strategic cooperation] Securities Times e Company NewsredmanbingoOn May 20, KangLoong Chemical Corporation announced that it will cooperate with AstraZeneca China to provide comprehensive services including small molecule, large molecule and cell and gene therapy drugs.redmanbingoResearch and development throughout the entire process of drug discovery, preclinical and clinical developmentredmanbingo.redmanbingo..

Newsletter text

[Kanglon Chemical Corporation and AstraZeneca China reach strategic cooperation] Securities Times e Company News, on May 20, Kanglon Chemical Corporation announced that it has reached a comprehensive strategic cooperation with AstraZeneca China on issues including small molecules, macromolecules, cells and gene therapy drugs., integrated R & D and commercial production services throughout the entire process of drug discovery, preclinical and clinical development, as well as investment in innovative drug research and development. At the same time, KangLoong Chemical Corporation plans to invest an additional 91 million yuan in Wuxi AstraZeneca CICC Venture Capital Fund. Both parties will give full play to the resources and experience advantages of the industry-leading medical and health field and the entire global industry chain to help the growth of innovative medical companies.